Abstract
Platelets play a central role in thrombosis, hemostasis, and inflammation. We show that activated platelets release inorganic polyphosphate (polyP), a polymer of 60-100 phosphate residues that directly bound to and activated the plasma protease factor XII. PolyP-driven factor XII activation triggered release of the inflammatory mediator bradykinin by plasma kallikrein-mediated kininogen processing. PolyP increased vascular permeability and induced fluid extravasation in skin microvessels of mice. Mice deficient in factor XII or bradykinin receptors were resistant to polyP-induced leakage. PolyP initiated clotting of plasma via the contact pathway. Ablation of intrinsic coagulation pathway proteases factor XII and factor XI protected mice from polyP-triggered lethal pulmonary embolism. Targeting polyP with phosphatases interfered with procoagulant activity of activated platelets and blocked platelet-induced thrombosis in mice. Addition of polyP restored defective plasma clotting of Hermansky-Pudlak Syndrome patients, who lack platelet polyP. The data identify polyP as a new class of mediator having fundamental roles in platelet-driven proinflammatory and procoagulant disorders.
Original language | English |
---|---|
Pages (from-to) | 1143-1156 |
Number of pages | 14 |
Journal | Cell |
Volume | 139 |
Issue number | 6 |
DOIs | |
Publication status | Published - 11 Dec 2009 |
Keywords
- animals
- blood platelets
- bradykinin
- factor XII
- fibrin
- Hermanski-Pudlak syndrome
- humans
- inflammation mediators
- mice
- peptide hydrolases
- plasma
- polyphosphates
- receptors, bradykinin
- thrombosis